Balili, John P.

HRN: 27-35-56  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/20/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
06/20/2025
06/26/2025
IV
600 Mg
Q6h
Inflamed Foot With Abscess
Remove - Pending Acceptance
06/20/2025
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
06/20/2025
06/26/2025
IV
1.5g
Q6h
Inflamed Foot With Abscess
Remove - Pending Acceptance

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: